What is the current Global Cell and Gene Therapy Manufacturing Services Market size?

March 2023: Thermo Fisher Scientific opened a cell therapy facility at the University of California, San Francisco (UCSF) to accelerate the development of breakthrough therapies for cancer, rare diseases, and other illnesses.
January 2022: AllogeneTherapeutics Inc. and AntionBiosciences Inc. entered into an exclusive collaboration and global license agreement for Antion'smiRNA technology (miCAR) to advance multiplex gene silencing as an additional tool to develop next-generation allogeneic CAR T products.

The Global Cell and Gene Therapy Manufacturing Services Market is projected to register a CAGR of 12.5% during the forecast period (2024-2029) Read More

Who are the key players in Global Cell and Gene Therapy Manufacturing Services Market?

Charles River Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd and Fujifilm Holdings Corporation are the major companies operating in the Global Cell and Gene Therapy Manufacturing Services Market. Read More

Which is the fastest growing region in Global Cell and Gene Therapy Manufacturing Services Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Cell and Gene Therapy Manufacturing Services Market?

In 2024, the North America accounts for the largest market share in Global Cell and Gene Therapy Manufacturing Services Market. Read More

What years does this Global Cell and Gene Therapy Manufacturing Services Market cover?

The report covers the Global Cell and Gene Therapy Manufacturing Services Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Cell and Gene Therapy Manufacturing Services Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More